Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRigbye, Kristin A-
dc.contributor.authorvan Hasselt, Peter M-
dc.contributor.authorBurgess, Rosemary-
dc.contributor.authorDamiano, John A-
dc.contributor.authorMullen, Saul A-
dc.contributor.authorPetrovski, Slavé-
dc.contributor.authorPuranam, Ram S-
dc.contributor.authorvan Gassen, Koen L I-
dc.contributor.authorGecz, Jozef-
dc.contributor.authorScheffer, Ingrid E-
dc.contributor.authorMcNamara, James O-
dc.contributor.authorBerkovic, Samuel F-
dc.contributor.authorHildebrand, Michael S-
dc.identifier.citationEpilepsy research 2016; 128: 48-51-
dc.description.abstractMutation of fibroblast growth factor 13 (FGF13) has recently been implicated in genetic epilepsy with febrile seizures plus (GEFS+) in a single family segregating a balanced translocation with a breakpoint in this X chromosome gene, predicting a partial knockout involving 3 of 5 known FGF13 isoforms. Investigation of a mouse model of complete Fgf13 knock-out revealed increased susceptibility to hyperthermia-induced seizures and epilepsy. Here we investigated whether mutation of FGF13 would explain other cases of GEFS+ compatible with X-linked inheritance. We screened the coding and splice site regions of the FGF13 gene in a sample of 45 unrelated probands where GEFS+ segregated in an X-linked pattern. We subsequently identified a de novo FGF13 missense variant in an additional patient with febrile seizures and facial edema. Our data suggests FGF13 is not a common cause of GEFS+.-
dc.titleIs FGF13 a major contributor to genetic epilepsy with febrile seizures plus?-
dc.typeJournal Article-
dc.identifier.journaltitleEpilepsy research-
dc.identifier.affiliationEpilepsy Research Centre, Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia -
dc.identifier.affiliationDepartment of Pediatric Gastroenterology and Metabolic Diseases, University Medical Centre (UMC) Utrecht, Utrecht 3584, The Netherlands-
dc.identifier.affiliationFlorey Institute and Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Victoria 3052, Australia-
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia-
dc.identifier.affiliationDepartments of Neurobiology and Neurology, Duke University Medical Center, Durham, NC 27710, USA-
dc.identifier.affiliationDepartment of Genetics, University Medical Centre (UMC) Utrecht, Utrecht 3584, The Netherlands-
dc.identifier.affiliationSchool of Medicine and Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia-
dc.identifier.affiliationSchool of Molecular and Biomedical Sciences, University of Adelaide, Adelaide, SA 5005, Australia-
dc.identifier.affiliationCenter for Translational Neuroscience, Duke University Medical Center, Durham, NC 27710, USA-
dc.type.austinJournal Article-, Samuel F
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.languageiso639-1en- Research Centre- Research Centre- Research Centre- Research Centre- (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Jun 12, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.